In addition, small interfering RNA-mediated MITF silencing in melanoma cells significantly reduces melanin content by inhibiting TYR, TYRP-1, and MC1R, which indicates that the transcriptional activation of MITF is a promising strategy for treating hypopigmentation [47]. The gene discussed is MITF; the disease is melanoma.